Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'

Affiliations

• ¹ Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Electronic address: lucie.heinzerling@med.uni-muenchen.de.
• ² II. Med. Klinik, Onkologie, Hämatologie, Immunologie, Infektiologie, Palliativmedizin Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany.
• ³ Department of Dermatology, Mühlenkreiskliniken AöR, Ruhr University Bochum Campus, Minden, Germany.
• ⁴ Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
• ⁵ Paul-Ehrlich Institut, Langen, Germany.
• ⁶ Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.